Enovis is well positioned in the orthopedic market, combining small-cap focus on product innovation with large-cap functionality, CEO Matt Trerotola tells Bloomberg Intelligence. That includes its commercial team, balance sheet and M&A, which let it penetrate some of the fastest-growing segments. In this Vanguards of Health Care podcast episode, Trerotola sits down with BI analyst Matt Henriksson for an in-depth interview about Enovis, how its technology has gained an edge in shoulders and ankles, how its focus on ambulatory surgical centers has created a niche in knees and hips and how it has honed its M&A prowess to continually add new innovation to its portfolio.

See omnystudio.com/listener for privacy information.